Lauren L. Ritterhouse

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma

Recommendations for Tumor Mutational Burden Assay Validation and Reporting

Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML

Prognostic biomarkers for survival in mucosal melanoma

Abstract CT228: Concordance between tissue and circulating tumor DNA (ctDNA) testing for neurotrophic tyrosine receptor kinase (<i>NTRK</i>) gene fusions in larotrectinib (laro) clinical trials

Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma

Uterine PEComas: correlation between melanocytic marker expression and TSC alterations/TFE3 fusions

Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations

Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay

<i>BAP1</i>-Mutated Clear Cell Renal Cell Carcinoma

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma

Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma

Loss of SMAD4 protein expression in gastrointestinal and extra‐gastrointestinal carcinomas

Germline <i>BRCA</i> -Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases

High <i>NPM1</i> mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia

Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma

Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center

Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing

Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma

Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations?

Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer

Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer

Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1